1 DRUG DISCOVERY Random Search e.g., buying paintbrush, mop, hammer, gluestick, nail, etc. etc. for hanging a picture frame on the wall Rational Design.

Slides:



Advertisements
Similar presentations
1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
Advertisements

The Drug Discovery Process
DRUG DEVELOPMENT The Long Road to a New Medicine
1 Statistical Work Experiences in a Major Pharmaceutical Company Qiming Liao, Ph.D Hui Zhi, Ph.D GlaxoSmithKline Pharmaceuticals, R&D Nov 4, 2011.
The 2 nd Clinical Data Management Training Innovative Drug Research and Development ( 创新药品的研发过程) Frank Shen (沈志华), Ph.D. Head of Biometrics and Clinical.
Key Questions WHO WHAT WHERE WHEN WHY HOW Pfizer Inc
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
9.7 Special Factors. a. 0 y y y-4y Ans:________________ (y+4)(y-4)
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Using the Quotient of Powers Property
Stages of drug development
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
Drug discovery and development
Combinatorial Chemistry and Library Design
Obtaining and Negotiatiing a Position in Industry/Biotech Roy G. Smith Ph.D. Director, Huffington Center on Aging Professor, Department of Molecular and.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Innovation Economics (Pt. 2): “Push” Mechanisms, Mostly Private-Public Partnerships Private-Public Partnerships Stephen M. Maurer Designing Strategies.
The Need for Organ Site Specific Cancer Research John T Isaacs Chemical Therapeutic Program Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Synthetic Cellulosome for Cellulosic Biofuel Synthesis Xi Song, Wei Niu, Jiantao Guo Department of Chemistry, University of Nebraska-Lincoln, Lincoln,
NIH Roadmap and Chemoinformatics Jeffery Loo NLM Associate Fellow Welch Library Journal Club 2004/12/7.
1 Combinatorial Synthesis and Drug Discovery Random Search e.g., buying paintbrush, mop, hammer, gluestick, nail, etc. etc. for hanging a picture frame.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 14 COMBINATORIAL CHEMISTRY Part 2: Sections 14.5 – 14.6.
Drug Discovery Process Massimiliano Beltramo, PhD.
Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,
1 Biological Discovery High Volume Screening Combinatorial Diversity Structure, Design, Informatics Lead Series Biodisposition Toxicity Efficacy Pharmacokinetics.
Combinatorial Chemistry. Synthesis of many structures (diversity) combinatorial technology, combinatorial library molecular diversity What is Combinatorial.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
The pharmaceutical R&D process years, costly ($30 Mn – $1300Mn)
The pharmaceutical R&D process
Introduction Over the last decade, solid phase synthesis and combinatorial chemistry have undergone major evolution. In the early years, the process of.
How are medicines developed?. What is it? What’s inside?
DEFINITION The automated synthesis of a large number of compounds in a short time period using a defined reaction route and a large variety of reactantsThe.
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
E-Clinical
신기술 접목에 의한 신약개발의 발전전망과 전략 LGCI 생명과학 기술원. Confidential LGCI Life Science R&D 새 시대 – Post Genomic Era Genome count ‘The genomes of various species including.
Pharmaceutical Approaches to Antiviral Drug Discovery
Molecular Modeling in Drug Discovery: an Overview
Combinatorial Chemistry
Презентацию подготовила Хайруллина Ч.А. Муслюмовская гимназия Подготовка к части С ЕГЭ.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Drug Development Process Stages involved in Regulating Drugs
Drug Design Geometrical isomerism Chirality
Drug UCIBIO Maria João Ramos
Drug Development Overview CET Square 1 Program November 4, 2014
Drug Discovery &Development
Rational Drug Discovery
Biotechnology Objectives: At the end of this lecture we will be able to identify and describe the uses of biotechnology in society.
Important Points in Drug Design based on Bioinformatics Tools
أهداف المحاضرة مراجعة المفاهيم والعلاقات الأساسية لتحليل العلاقة بين التكاليف والحجم والربح. بناء نموذج لتحليل التعادل في حالة وجود منتج وحيد. بناء نموذج.
Process of Drug Discovery
“Structure Based Drug Design for Antidiabetics”
Lixia Yao, James A. Evans, Andrey Rzhetsky  Trends in Biotechnology 
Driving Glioblastoma to Drink
1 (x+1)(x+3) (x-3)(x+2) (x-1)(x+3) x2+2x-3 (x+6)(x-2) (x+1)(x-3)
Protein microarrays: prospects and problems
Important Points in Drug Design based on Bioinformatics Tools
Drug Design and Drug Discovery
Combinatorial peptide library methods for immunobiology research
Index Laws Objectives:
Volume 21, Issue 9, Pages (September 2014)
Nina Svensen, Juan José Díaz-Mochón, Mark Bradley  Chemistry & Biology 
BETONLINEBETONLINE A·+A·+
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
Manufacturing, Marketing Pharmaceutical development
Presentation transcript:

1 DRUG DISCOVERY Random Search e.g., buying paintbrush, mop, hammer, gluestick, nail, etc. etc. for hanging a picture frame on the wall Rational Design e.g., buying a nail for hanging the frame Combinatorial Search e.g., buying a box of nails of different sizes for hanging the frame

2 ~ 5 IND ~ 250 in vivo ~ 500 in vitro > 10,000 compounds > 15 years ~ 1 NDA > $500 million Time Cost WHY COMBINATORIAL CHEMISTRY?

3 Biological Discovery High Volume Screening Combinatorial Diversity Structure, Design, Informatics Lead Series Biodisposition Toxicity Efficacy Pharmacokinetics IND Lead Discovery Iterative Preclinical Research Process R&D FULL TOOLBOX REQUIRED TO COMPETE

4 GENERATING A COMBINATORIAL LIBRARY XXXYYY + ……….. 9 products  MIXTURE SYNTHESIS

5 Ser Ala Tyr Arg  SPATIALLY ADDRESSABLE SYNTHESIS XY + I) XY + II) X Y + III)

6  SPLIT AND MIX STRATEGY X XX Y Y YY MIX SPLIT

7  SPLIT AND MIX STRATEGY MIX and SPLIT

8  DECONVOLUTION BY TAGGING Y Y YY X XX MIX SPLIT

9  DECONVOLUTION BY TAGGING (continued) MIX and SPLIT

10  DECONVOLUTION BY ENCODED DNA MIX and SPLIT SPLIT A1 N1 A2 N2 A3 N3 A2A2 A1A2 N1N2N2N2 A3A2 N3N2 A2A1 A1A1 N1N1N2N1 A3A1 N3N1 A2A3 A1A3 N1N3N2N3 A3A3 N3N3 A2 A3 A1